ReviewBritish journal of cancer2008
Lung cancer screening: the way forward.
Review in British journal of cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.
- Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2010Pooled it
- Trial
- Epidemiological characteristics and risk factors of lung cancer in a population with incidental pulmonary nodules in China: a prospective multicenter study of 10,560 cases.Journal of the National Cancer Center · 2026Article
- Implementation planning for lung cancer screening in China.Precision clinical medicine · 2019Review
- MLN4924 neddylation inhibitor promotes cell death in paclitaxel-resistant human lung adenocarcinoma cells.Oncology letters · 2018Article
- Article
- Lung Cancer Early Detection: The Role of Circulating MicroRNAs.EBioMedicine · 2015Article
- STAT1 modification improves therapeutic effects of interferons on lung cancer cells.Journal of translational medicine · 2015Article
- Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer.Cancer medicine · 2014Article
- Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom.British journal of cancer · 2014Article
- Long survival of a small-cell lung cancer patient who received maintenance chemotherapy with irinotecan.Case reports in oncology · 2013Article
- Ionizing radiation potentiates dihydroartemisinin-induced apoptosis of A549 cells via a caspase-8-dependent pathway.PloS one · 2013Article
- Apoptosis Effect of Girinimbine Isolated from Murraya koenigii on Lung Cancer Cells In Vitro.Evidence-based complementary and alternative medicine : eCAM · 2013Article
- Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study.Annals of internal medicine · 2012Article
- Article
- The potential for using risk models in future lung cancer screening trials.F1000 medicine reports · 2010Article
- Treatment options for small cell lung cancer - do we have more choice?British journal of cancer · 2010Review
- Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON).British journal of cancer · 2010Article
- Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer.OncoimmunologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
To take lung cancer screening into national programmes, we first have to answer the question whether low-dose computed tomography (LDCT) screening and treatment of early lesions will decrease lung cancer mortality compared with a control group, to accurately estimate the balance of benefits and harms, and to determine the cost-effectiveness of the intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.